What creams promise and what is actually known
What it is
A copper peptide is a short molecule with copper inside.
- a peptide is a chain of several amino acids
- copper is attached to it like an anchor
- it is added to creams and serums
Where the expectations come from
The expectations are linked to the skin's collagen.
- collagen keeps skin firm
- copper is needed by the enzyme that cross-links it
- that is the idea, but the result for a person depends on the product
Does it pass through the skin
The molecule is charged and mixes well with water.
- it passes poorly through intact skin
- so it is combined with procedures
- this changes the risk of irritation too
Wounds
This peptide did best in a gel for wounds.
- the most striking result is in foot ulcers in diabetes
- the gel is applied to the wound, not to healthy skin
- that study came out long ago
After procedures
After laser, a cream with a copper peptide gave no clear advantage.
- doctors and a photo-analysis program found no noticeable difference
- patients themselves rated their skin higher
- the products in the groups differed in more than the peptide
Wrinkles
Promises about wrinkles sound louder than the evidence.
- the loud figures come from a conference
- there are no full data there
- judge the specific cream, not the words on the jar
Hair
For hair, the peptide is usually part of a mixture.
- other drugs are working alongside
- the peptide's own contribution is not visible separately
- hair loss starts with looking for the cause
Eyebrows
For eyebrows there was a small blinded comparison.
- there were few participants
- the serum was applied for three months
- this says nothing about hair on the head
Mixtures
Ready-made products usually contain many substances.
- the peptide is one of five or six
- the result is attributed to the whole mixture
- pure copper peptide has rarely been tested on its own
Similar names
Similar names mean different substances.
- a peptide with copper
- the same peptide without copper
- a version with a fatty tail, without copper
The AHK-Cu product
AHK-Cu is an analogue of GHK-Cu with alanine.
- a related copper peptide
- it is added to hair products
- judge the specific product
Injections
Injections with a copper peptide are outside the rules.
- they are not registered as a drug
- nobody checks the quality of such products in a uniform way
- do not inject them yourself
Who should see a doctor first
There are cases when you cannot do without a doctor.
- any wounds, especially in diabetes
- pregnancy and breastfeeding
- metal allergy or hair loss
Important. A doctor assesses a wound and the cause of hair loss, not a cream from a label.
The main point
Look at the specific product, not at the words "copper peptides".
- the peptide did best in a gel for wounds
- for skin and hair the data are more modest
- make decisions together with a doctor
The main point
Copper peptides are products for the skin and scalp that contain GHK-Cu (a complex of the three amino acids glycyl-histidyl-lysine with copper) or the closely related AHK-Cu (alanyl-histidyl-lysine with copper). They are discussed for wrinkles, after cosmetic procedures, for scars, and for hair and eyebrows. The largest result for GHK-Cu was obtained in diabetic foot ulcers: in a multicenter study from 1994 the median ulcer closure was 98.5% of the area versus 60.8% on a vehicle gel (P < 0.05; the number of participants is not stated in the abstract). For creams and serums the picture is more modest: in the only randomized study with blinded assessors after CO₂ laser (13 people), no significant objective difference between the groups was shown, and only the patients' own rating was higher (P = 0.04). Most studies tested multi-ingredient products, so below we write "a product with a copper peptide" rather than "pure GHK-Cu".
| Substance and form | What it does | What the studies showed | Who it is discussed for |
|---|---|---|---|
| GHK-Cu, wound gel | a peptide-copper complex is applied to damaged skin | diabetic foot ulcers: median closure 98.5% versus 60.8% on the vehicle, P < 0.05, 1 multicenter study, n not stated in the abstract | adults with a neuropathic foot ulcer (indication not registered) |
| Product with GHK-Cu after CO₂ laser | skin care after resurfacing | 13 people, 1 study: no significant difference was shown for erythema, wrinkles and skin quality; patient questionnaire P = 0.04 | people after laser resurfacing |
| Serum with 2% GHK-Cu on eyebrows | applied for 12 weeks | 18 people, split face; more hairs and thicker, no figures | sparse eyebrows (journal not indexed in PubMed) |
| Mixtures with a copper peptide on the scalp | applied or injected into the skin | the peptide's contribution is not separated out: alongside are minoxidil, dutasteride, finasteride or five other substances | hair loss |
How it works
GHK is a short chain of three amino acids that easily binds copper; the finished complex is called GHK-Cu. According to the review authors, GHK resembles a fragment of collagen and acts as a signal for skin cells, while copper is needed by the enzyme that cross-links collagen and elastin fibers. This is how the substance works; it does not explain what a person gets from a cream. The peptide is charged and dissolves well in water, and, by the shared conclusion of the 2026 reviews, passes poorly through the intact outer layer of the skin. A rise in a collagen marker is not the same as restoring the skin's structure (Yi et al., Life 2026, PMID 42942246[1]).
Three similar names denote different substances: GHK without copper ("tripeptide-1" in cosmetics), GHK-Cu with copper, and palmitoyl tripeptide-1 with a fatty tail but without copper. Results from one form cannot be carried over to another: the 2026 reviews came to this conclusion (PMID 42942246[1], PMID 42797253[2]). No clinical study states how much copper is bound to the peptide.
Wounds: diabetic foot ulcer
The strongest positive study of GHK-Cu came out in 1994 (Mulder et al., Wound Repair Regen, PMID 17147644[3]). A multicenter randomized study with a blinded assessor and a vehicle control was conducted in adults with neuropathic diabetic foot ulcers. All participants received strict standard care: surgical debridement, daily application of a measured dose, offloading footwear, and diabetes-control education.
The median closure of plantar ulcers was 98.5% of the area versus 60.8% on the vehicle (P < 0.05), and they closed three times faster. For large ulcers (over 100 mm² at the start) the median was 89.2% versus −10.3% (P < 0.01): on the vehicle such ulcers grew on average. Infected ulcers were 7% versus 34% (P < 0.05), but only among those whose treatment began right after the first debridement. The authors state outright that this is a condition for the best result.
The number of participants is not stated in the abstract, the study is 32 years old, and the indication was never registered. It was not included in the list of clinical studies in the 2026 Mateescu review. These figures cannot be carried over to anti-wrinkle creams: there is no wound and no open barrier there, the skin is different and so is the regimen.
After laser, microneedles and other procedures
The only randomized study of care after CO₂ laser was done with blinded assessors (Miller et al., Arch Facial Plast Surg 2006, PMID 16847171[4]). After resurfacing of the skin around the mouth, participants were divided into care with GHK-Cu and without it; 13 people completed the study. A computer and blinded assessors found no significant difference in earlier disappearance of erythema. Wrinkles and skin quality improved in everyone, but no significant difference between the groups was shown. Only the patients' own rating was significant: overall skin quality, P = 0.04.
For the combination with microneedling (a dermaroller), acne scars were compared on a split face: GHK-Cu serum 0.5–1% together with the roller versus the roller alone. According to a systematic review, there was early improvement in the combined group, but by week 16 no significant difference between the sides remained, and the authors noted a risk of hyperpigmentation in the GHK-Cu group (Najafi et al., Arch Intern Med Res 2026, PMID 42787770[5]). The review does not give the number of participants. No full-text randomized study of GHK-Cu with microneedles has been published.
Almost all randomized trials of the "GHK peptide" after procedures were done on the copper-free form (tripeptide-1 together with hexapeptide-12), and that is a different substance. The most rigorous of them (Liu et al., Dermatol Ther 2026, PMID 42322532[6]) included two randomized split-face studies with a blinded assessor, 26 and 25 people, after fractional CO₂ laser and radiofrequency microneedling. The main endpoint, erythema, did not differ significantly between the sides in either of the two; for some secondary ones (swelling, water loss through the skin) the serum side recovered better. Three of the authors work for the manufacturing company and themselves call the results exploratory.
Wrinkles and skin quality
Advertising promises rest on work without full publication. Abstracts from a 2002 dermatology congress described 71 and 41 women, but there are no methods, no peer review and no full text. A 2016 assessment of wrinkles in volunteers appeared in a journal outside PubMed, with the number of participants not stated. A 2026 systematic review included 20 studies, 2 of them randomized: according to its abstract, patient satisfaction after laser was higher, and the volume and depth of wrinkles decreased compared with control, while the number of well-designed clinical studies is limited (Mokhtar et al., Aesthet Surg J 2026, PMID 42619529[7]).
Hair and eyebrows
The only recent blinded study with a vehicle control concerns eyebrows: randomized, double-blind, split-face, 18 healthy participants, 12 weeks, serum with 2% GHK-Cu. According to the Mateescu review, the number and diameter of eyebrow hairs improved and there were no serious adverse events, but the review does not give the size of the gain. The study appeared in a journal that PubMed does not index, and it does not describe the composition of the product.
For hair loss on the scalp, mixtures are more often used. In a case series with tattoo-style application of minoxidil, dutasteride and copper peptides, the hair-bearing area grew by 26.5% on blinded automated assessment of photographs (as reported in the Najafi review), but the number of participants is not stated, and two hair-loss drugs were acting alongside (Kuceki et al., JAAD Int 2025, PMID 40225275[8]). In a series of four cases, a fractional laser was combined with topical finasteride, growth factors and a 1% copper peptide; all four showed a positive response, but the peptide's contribution is not separated out (Bertin et al., J Cosmet Laser Ther 2018, PMID 29452017[9]).
The largest body of data relates to the QR678 formula: it contains six substances (four growth factors, thymosin beta-4 and one copper peptide), injected into the scalp skin in 8 sessions 3–4 weeks apart. In an open-label study of 1000 people, hair loss on the pull test decreased in 83% (Kapoor et al., J Cosmet Laser Ther 2018, PMID 29482481[10]). In a multicenter open-label phase IV study of 2428 people, after 8 sessions the test was positive in only 12% (Asper, Shome, Kapoor et al., J Cosmet Dermatol 2022, PMID 34997995[11]). The studies are open-label, without a control group, carried out by the owners of the formula, and the contribution of the copper peptide was not separated out in either.
A systematic review of peptides for hair screened 981 papers, and 14 clinical studies met the criteria. Formulas with GHK, acetyl tetrapeptide-3, biotinoyl tripeptide-1 and a pentapeptide received recommendation grade B, QR678 formulas grade C (Joerg et al., J Drugs Dermatol 2026, PMID 42976838[12]). This is a rating of peptide combinations, not of GHK-Cu alone. More: Ferritin and hair and Eastern remedies for hair loss.
AHK-Cu is a related copper peptide, an analogue of GHK-Cu with alanine; it is added to hair products.
Scalp and mixtures
The Mateescu review reads the Miller study as a warning against inflated promises, not as proof that there is no effect: with 13 participants it cannot rule out a moderate effect (Mateescu et al., Pharmaceutics 2026, PMID 42797253[2]).
Mixtures with copper-GHK have also been studied for other aims: in one 59-year-old man, wrinkles around the eye decreased after jet delivery of a five-component mixture (PMID 27064823[13]), and in melasma the melanin and erythema indices fell, but the mixture contained tranexamic acid, which has its own effect (Chae et al., J Cosmet Dermatol 2017, PMID 28133891[14]). The peptide's contribution is not separated out in these studies.
A serum with copper tripeptide-1 for the scalp (an open-label study without control, about 29 people by the fractions in the abstract, 15 days) lowered the adherent scale score (ASFS) by 61.24% (P < 0.0001). Alongside in the formulation were a scrub with hydroxy acids and four more components, and the product was made by the study sponsor, so the peptide's contribution is not separated out (Patel et al., Cureus 2024, PMID 39449909[15]).
How it is used
GHK-Cu has no registered indication in the sources studied: it is used as a cosmetic ingredient, and no regulatory dosing instructions exist. So below is only what was tested in the studies.
Concentrations in clinical studies: 0.1% gel in an ongoing phase 2 study in acute wounds (about 0.5 g in a thin layer once a day, 14 days; estimated 60 participants, sponsored by the manufacturer, no results yet, NCT07437586), 0.5–1% serum under a dermaroller, 1% in a mixture after laser, 2% serum on eyebrows for 12 weeks. For the finished products in the Miller study and the 2002 abstracts the concentration is not disclosed. The route in all GHK-Cu studies is topical; a copper peptide was injected into the skin only inside the QR678 mixture (1.0–1.5 mL per session, 8 sessions). The longest follow-up of GHK-Cu without other substances lasted 12 weeks.
According to the 2026 Najafi review, since 2023 the US Food and Drug Administration has placed GHK-Cu in category 2, with a restriction on pharmacy compounding of injectable forms. Injectable copper-peptide preparations outside a registered indication, according to the 2026 Mateescu review, sit outside any defined quality-assessment system, and an adverse event after a depot is placed is hard to reverse.
Who should see a doctor first
A doctor is needed for any wound, especially foot ulcers in diabetes: a cream does not replace dressings and offloading of the foot. See a specialist before procedures that damage the skin (laser, radiofrequency, microneedles): after them the products are chosen by the doctor. In pregnancy, while breastfeeding, in children and for use longer than 12 weeks, discuss it with a doctor first.
Contact sensitization to copper is possible in predisposed people, and in one study of acne scars the authors noted a risk of hyperpigmentation. For hair loss, the causes come first: ferritin, the thyroid, deficiencies. If copper as a trace element by mouth is discussed in a regimen, remember the rule: zinc displaces copper, so if you take zinc or it is in your other vitamins, taking copper is essential. More: Zinc: why it is needed, signs of deficiency and how much is safe.
What the studies showed
| What was studied | Who and how many | Result | Source |
|---|---|---|---|
| GHK-Cu gel in a diabetic foot ulcer | multicenter RCT, n not stated | closure 98.5% versus 60.8% (median), P < 0.05; infections 7% versus 34% with early start | Mulder Wound Repair Regen 1994. PMID 17147644[3] |
| Care with GHK-Cu after CO₂ laser | 13 people, 1 RCT with a blinded assessor | no significant difference shown for erythema, wrinkles, skin quality; questionnaire P = 0.04 | Miller Arch Facial Plast Surg 2006. PMID 16847171[4] |
| Roller with GHK-Cu serum 0.5–1% for acne scars | split face, 1 study from 2025, n not stated (per the review) | no significant difference by week 16; hyperpigmentation signal | Najafi Arch Intern Med Res 2026. PMID 42787770[5] |
| All clinical studies of GHK-Cu | 4 studies from 1998–2026 | including abstracts and one with a negative result on objective endpoints | Mateescu Pharmaceutics 2026. PMID 42797253[2] |
| GHK-Cu in aesthetic medicine | 20 studies, 2 of them RCTs | satisfaction after laser higher, wrinkles smaller versus control, few well-designed studies | Mokhtar Aesthet Surg J 2026. PMID 42619529[7] |
| Minoxidil, dutasteride and a copper peptide by tattoo-style application | case series, n not stated | hair-bearing area +26.5%, peptide's contribution not separated out | Kuceki JAAD Int 2025. PMID 40225275[8] |
| Laser with finasteride, growth factors, 1% copper peptide | 4 cases | improvement in all four, no control | Bertin J Cosmet Laser Ther 2018. PMID 29452017[9] |
| Jet delivery of a mixture with copper-GHK | 1 man aged 59 | wrinkles around the eye decreased over 12 weeks | Byun J Cosmet Laser Ther 2016. PMID 27064823[13] |
| Mixture with copper-GHK in melasma | small group, n not stated | melanin and erythema indices lower, tranexamic acid present | Chae J Cosmet Dermatol 2017. PMID 28133891[14] |
| Serum with copper tripeptide-1 for the scalp | about 29 people, open-label, 15 days | ASFS −61.24%, P < 0.0001; sponsor's product | Patel Cureus 2024. PMID 39449909[15] |
| QR678 formula, first study | 1000 people, open-label | hair loss on the pull test lower in 83% | Kapoor J Cosmet Laser Ther 2018. PMID 29482481[10] |
| QR678 Neo formula, phase IV | 2428 people, open-label, no control | pull test positive in 12% after 8 sessions | Asper, Shome, Kapoor J Cosmet Dermatol 2022. PMID 34997995[11] |
| Peptides for hair, systematic review | 981 found, 14 included | GHK combinations: grade B; QR678: grade C | Joerg J Drugs Dermatol 2026. PMID 42976838[12] |
| Copper-free GHK after laser and microneedling | 26 and 25 people, 2 RCTs | main endpoint (erythema) did not differ significantly; swelling and water loss through the skin better | Liu Dermatol Ther 2026. PMID 42322532[6] |
| Copper-free GHK for fragile skin of the hands | 38 people, RCT, 24 weeks | dermal-epidermal junction better in 83% versus 17% on a ceramide cream | Markowitz J Drugs Dermatol 2024. PMID 39630663[16] |
| Copper-free GHK after fractional laser | 15 women (14 analyzed), RCT | healing better on day 7 | Vanaman Wilson J Cosmet Dermatol 2017. PMID 28371204[17] |
| Peptides in aesthetic dermatology | review | conclusions apply to the product, not to the class of substances | Yi Life 2026. PMID 42942246[1] |
Summary
Copper peptides are best studied as a gel for wounds: diabetic foot ulcers closed noticeably more fully than on the vehicle. For anti-wrinkle creams, care after laser and hair products the data are more modest: the blinded study after laser (13 people) showed no significant objective difference, combinations with other active ingredients do not allow the peptide's contribution to be separated out. What should be judged is the specific product, not the words on the label. Decisions about wound treatment, procedures and hair loss are made together with a doctor. You can discuss your questions at a consultation.
References
Key facts
- GHK-Cu is not registered as a drug for any indication: it is used as a cosmetic ingredient, and injectable forms are outside registration.
- Diabetic foot ulcers: GHK-Cu gel closed ulcers by 98.5% of their area versus 60.8% on the vehicle (median, P < 0.05), 1 multicenter study from 1994, n not stated in the abstract.
- Care after CO₂ laser: 13 people completed 1 randomized study with blinded assessors; no significant difference was shown for erythema, wrinkles and skin quality, and only the patients' own rating was higher (P = 0.04).
- For acne scars with microneedling, according to a systematic review, no significant difference between the sides remained by week 16.
- The QR678 hair formula with one copper peptide among six substances: in an open-label study of 2428 people after 8 sessions the pull test was positive in 12%, and the peptide's contribution was not separated out.
- Serum with 2% GHK-Cu on eyebrows for 12 weeks: in 18 people there were more hairs and they were thicker, no figures (journal not indexed in PubMed).




